Abel Abraham
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Abel Abraham has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Myeongsub Kim
Department of Ocean and Mechanical Engineering, Florida Atlantic University, Boca Raton, FL 33431, USA
2 shared publications - Abhishek Ratanpara
Department of Ocean and Mechanical Engineering, Florida Atlantic University, Boca Raton, FL 33431, USA
1 shared publication - Anjelli Wignakumar
Ellen Leifer Shulman and Steven Shulman Digestive Disease Center Cleveland Clinic Weston Florida USA
1 shared publication Ayush Gowda
Department of Ocean and Mechanical Engineering, Florida Atlantic University, Boca Raton, FL, 33431, USA
1 shared publication- Christopher Lopez
Ellen Leifer Shulman and Steven Shulman Digestive Disease Center Cleveland Clinic Weston Florida USA
1 shared publication - James Burns
Ellen Leifer Shulman and Steven Shulman Digestive Disease Center Cleveland Clinic Weston Florida USA
1 shared publication
Latest Publications
- 29 October 2026
- Published by Wiley in Journal of Surgical Oncology
Characteristics and Survival of Patients With Colonic Compared to Rectal Neuroendocrine Tumors: A SEER Registry Analysis
Introduction: Colon and rectal neuroendocrine tumors (NETs) have varying disease behaviors, presentations, and outcomes. Rectal NETs are detected early; colonic NETs present later and more aggressively. We compared demographic, tumor, treatment, and survival characteristics of colonic versus rectal NETs. Methods: This retrospective cohort study used SEER data (2000–2022) to identify adults with colonic or rectal NETs. Demographic, tumor, and treatment characteristics were compared by tumor site. Five‐year overall survival (OS) and cancer‐specific survival (CSS) were analyzed using Kaplan–Meier statistics and multivariable Cox proportional hazards regression. Additional site‐specific analyses evaluated stage and treatment patterns by race, ethnicity, and household income. Results: Twenty‐four percent of 30 246 patients had colonic NETs, and 76.0% had rectal NETs. Rectal NET patients were younger (55.7 vs. 62.9 years, p < 0.001) and more often Black, Asian, or Hispanic. Colonic NETs were more frequently poorly differentiated (43.9% vs. 7.0%), larger (median 30 vs. 5 mm), and more likely to have liver metastases (27.7% vs. 3.7%). Rectal NETs underwent local excision (92.1%), colonic NETs required colectomy (72.3%). Rectal NETs demonstrated higher 5‐year OS (88.8% vs. 55.8%) and CSS (93.8% vs. 58.2%, p < 0.001). Stage III colonic NETs had higher CSS than rectal NETs (67.3% vs. 53.5%, p < 0.001). Conclusion: Colonic and rectal NETs have distinct clinicopathologic profiles, treatment patterns, and stage‐specific outcomes. These findings support site‐specific evaluation while emphasizing the importance of stage and tumor biology in prognosis.
- 29 October 2026
- Published by Wiley in Journal of Surgical Oncology
Characteristics and Survival of Patients With Colonic Compared to Rectal Neuroendocrine Tumors: A SEER Registry Analysis
Introduction: Colon and rectal neuroendocrine tumors (NETs) have varying disease behaviors, presentations, and outcomes. Rectal NETs are detected early; colonic NETs present later and more aggressively. We compared demographic, tumor, treatment, and survival characteristics of colonic versus rectal NETs. Methods: This retrospective cohort study used SEER data (2000–2022) to identify adults with colonic or rectal NETs. Demographic, tumor, and treatment characteristics were compared by tumor site. Five‐year overall survival (OS) and cancer‐specific survival (CSS) were analyzed using Kaplan–Meier statistics and multivariable Cox proportional hazards regression. Additional site‐specific analyses evaluated stage and treatment patterns by race, ethnicity, and household income. Results: Twenty‐four percent of 30 246 patients had colonic NETs, and 76.0% had rectal NETs. Rectal NET patients were younger (55.7 vs. 62.9 years, p < 0.001) and more often Black, Asian, or Hispanic. Colonic NETs were more frequently poorly differentiated (43.9% vs. 7.0%), larger (median 30 vs. 5 mm), and more likely to have liver metastases (27.7% vs. 3.7%). Rectal NETs underwent local excision (92.1%), colonic NETs required colectomy (72.3%). Rectal NETs demonstrated higher 5‐year OS (88.8% vs. 55.8%) and CSS (93.8% vs. 58.2%, p < 0.001). Stage III colonic NETs had higher CSS than rectal NETs (67.3% vs. 53.5%, p < 0.001). Conclusion: Colonic and rectal NETs have distinct clinicopathologic profiles, treatment patterns, and stage‐specific outcomes. These findings support site‐specific evaluation while emphasizing the importance of stage and tumor biology in prognosis.
- 26 August 2023
- Published by Elsevier in Journal of Environmental Management
- Vol. 345, 118760
Towards green carbon capture and storage using waste concrete based seawater: A microfluidic analysis
- 26 August 2023
- Published by Elsevier in Journal of Environmental Management
- Vol. 345, 118760
Towards green carbon capture and storage using waste concrete based seawater: A microfluidic analysis